Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast CancerGlobeNewsWire · 5 days ago
Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company's Pipeline of Women's Health Innovations, Corporate Strategy and OpportunitiesGlobeNewsWire · Oct 13, 2026
Contrasting RYTHM (NASDAQ:RYM) & Dare Bioscience (NASDAQ:DARE)Defense World · Oct 13, 2026
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV InfectionGlobeNewsWire · Sep 28, 2026
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral SildenafilGlobeNewsWire · Sep 14, 2026
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-DemandGlobeNewsWire · Sep 11, 2026Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$0.30 | -$0.20 | Beat |
| May 14, 2026 | -$0.33 | -$0.20 | Beat |
| Mar 26, 2026 | -$0.24 | -$0.02 | Beat |
| Nov 13, 2025 | -$0.33 | -$0.28 | Beat |
| Aug 14, 2025 | -$0.55 | -$0.45 | Beat |
| May 13, 2025 | -$0.63 | -$0.50 | Beat |